• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Endo Launches Spatial Computing Injection Simulator with Apple Vision Pro for Medical Training

by Fred Pennic 03/26/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Endo, a pharmaceutical company, is breaking new ground in healthcare education with the launch of its innovative Spatial Computing Injection Simulator. 

– The first-of-its-kind initiative leverages the power of spatial computing, also known as “mixed reality,” to create a fully immersive learning environment for healthcare providers using Apple Vision Pro.

XIAFLEX® and the Simulator’s Purpose

Endo designed this simulator to help hand specialists refine their injection technique for the administration of XIAFLEX® (collagenase clostridium histolyticum). XIAFLEX® is the only FDA-approved non-surgical treatment for Dupuytren’s contracture when a “cord” can be felt. Dupuytren’s contracture is a condition caused by a buildup of collagen in the hand, which forms a rope-like cord that pulls fingers toward the palm, limiting their ability to straighten.

The Immersive Experience

The Spatial Computing Injection Simulator provides a unique learning experience by enabling providers to interact with both physical objects and digital content simultaneously, using a lifelike hand simulator model and an Apple Vision Pro app.

During the immersive, 20-minute session, hand specialists can:

  • Receive “hands-on” practice on reconstitution.
  • Learn about injection angles.
  • Watch procedures in action.
  • Practice their injection technique on the hand model.
  • Acquire information on the post-injection process.

This immersive training aims to help healthcare providers refine their injection techniques for treating patients with XIAFLEX®, which involves injecting the medication into the collagen “cord” causing the hand contracture.

Positive Early Reception

Endo recently previewed the Spatial Computing Injection Simulator at two prominent medical conferences, generating significant interest and positive feedback. At both the American Society for Surgery of the Hand (ASSH) and the American Association for Hand Surgery (AAHS) annual meetings, healthcare providers eagerly tested the technology, with more than 600 hand specialists using the simulator.

“The Spatial Computing Injection Simulator represents a major leap forward in enhancing patient care through a groundbreaking educational tool,” said Justin Mattice, Senior Vice President & General Manager, Branded Specialty at Endo. “We’re proud to pioneer this capability in the pharmaceutical industry, paving the way for future innovations that will help transform how healthcare professionals learn and gain hands-on experience.”

Availability and Development

Endo’s orthopedics sales team is now equipped to offer this innovative experience to healthcare providers. Endo collaborated with technology agency Lucid Dream to develop the Apple Vision Pro app and spatial computing experience.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |